Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $248000.0.

  • Wave Life Sciences' Capital Expenditures fell 3524.8% to $248000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $805000.0, marking a year-over-year decrease of 3336.09%. This contributed to the annual value of $938000.0 for FY2024, which is 1587.44% down from last year.
  • Latest data reveals that Wave Life Sciences reported Capital Expenditures of $248000.0 as of Q3 2025, which was down 3524.8% from $306000.0 recorded in Q2 2025.
  • Wave Life Sciences' Capital Expenditures' 5-year high stood at $492000.0 during Q2 2022, with a 5-year trough of $15000.0 in Q4 2021.
  • In the last 5 years, Wave Life Sciences' Capital Expenditures had a median value of $208000.0 in 2022 and averaged $247000.0.
  • As far as peak fluctuations go, Wave Life Sciences' Capital Expenditures tumbled by 9730.7% in 2021, and later soared by 126000.0% in 2022.
  • Wave Life Sciences' Capital Expenditures (Quarter) stood at $15000.0 in 2021, then skyrocketed by 1260.0% to $204000.0 in 2022, then skyrocketed by 74.51% to $356000.0 in 2023, then tumbled by 75.84% to $86000.0 in 2024, then soared by 188.37% to $248000.0 in 2025.
  • Its Capital Expenditures stands at $248000.0 for Q3 2025, versus $306000.0 for Q2 2025 and $165000.0 for Q1 2025.